Aedifica reports EUR 292.31 million sales and Aedifica stock gains 1.31 percent

Published on 10/13/2026 at 14:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Net income hit EUR 509.57 million in the first half of 2026. Aedifica stock costs EUR 61.95 on October 13, 2026, up 1.31 percent versus the Euronext close.

Array

Syensqo S.A. (BE0003851681) - Flatlay — Syensqo S.A. (BE0003851681) als Flatlay-Komposition mit Aktienzertifikat, ISIN-Karte und branchentypischen Objekten von oben fotografiert, Illustration mit AI erstellt.

Aedifica (ISIN BE0003851681) reported EUR 292.31 million in sales for the first half of 2026, while net income reached EUR 509.57 million. Simply Wall St published those figures on September 14, 2026, giving the latest reported earnings picture for the healthcare real estate group. Aedifica stock was trading at EUR 61.95 at Lang & Schwarz on October 13, 2026 at 2:06 p.m. CEST, 1.31 percent above the Euronext Brussels close of October 12, 2026 at EUR 61.15.

Half-year income sets the benchmark

Basic earnings per share from continuing operations reached EUR 7.28 in the first half of 2026, according to Simply Wall St on September 14, 2026. The same report said management outlined a proposed gross dividend of EUR 4.20 per share for fiscal year 2026, a 5.00 percent increase.

The mix matters for income-oriented investors because the proposed payout rose while the first-half earnings base included EUR 509.57 million of net income. The figures also give the valuation a direct earnings reference rather than relying only on the share price.

Stock stays below its yearly high

Aedifica's Lang & Schwarz bid was EUR 61.90 and the ask was EUR 62.00 at 2:06 p.m. CEST on October 13, 2026. The stock's 52-week range was EUR 60.35 to EUR 80.05, placing the current euro price 22.61 percent below the high and 2.65 percent above the low.

The Euronext Brussels quote was EUR 62.10 at 1:54 p.m. CEST on October 13, 2026, while the listed volume was 14,896 shares against an average volume of 108,942 shares. The Lang & Schwarz indication therefore remained close to the home-market quotation during the session.

Valuation and peer comparison

Aedifica had a market capitalization of EUR 3.1 billion, a P/E ratio of 5.45 and a trailing dividend yield of 6.00 percent on October 13, 2026. Its home-market profile is healthcare real estate, with the company listed on Euronext Brussels under AED.

Comparison with peers

Aedifica: plus 1.31 percent, P/E 5.45, market capitalization EUR 3.1 billion

Warehouses De Pauw (Euronext Brussels, EUR): plus 0.68 percent, P/E 11.24, market capitalization EUR 4.6 billion

Care Property Invest (Euronext Brussels, EUR): plus 1.51 percent, P/E 7.60, market capitalization EUR 512.0 million

Price remains the daily anchor

The current quote combines a 1.31 percent gain against the Euronext Brussels close of October 12, 2026 with a valuation multiple below those of the two named Belgian real estate peers. The next visible earnings reference is the half-year performance reported on September 14, 2026, while the proposed EUR 4.20 dividend keeps cash distribution central to the investment case.

The further course of trading is shown by the continuously updated real-time quote of Aedifica stock.